Article thumbnail

Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer

By Neill Patani, Wen G Jiang and Kefah Mokbel
Topics: Primary Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3156720
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). AE: On Trk–the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res
  2. (2008). B: A possible role of BDNF in prostate cancer detection. Oncol Rep
  3. (2008). BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation.
  4. (2006). Bieche I: Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer
  5. (2000). BL: Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development
  6. (1996). Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues.
  7. (2009). Cheung AN: Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome. Cancer Lett
  8. (2001). DR: Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci
  9. (2006). Drell TLt, Zaenker KS: Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med Hypotheses
  10. (2005). E: Neurotrophin system expression in human pulmonary carcinoid tumors. Growth Factors
  11. (2005). et al: Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors.
  12. (2005). et al: Overexpression of tropomysinrelated kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res
  13. (2008). et al: Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma. Oncology
  14. et al: TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
  15. (2001). Evans AE: Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms’ tumor.
  16. (2003). Expression of peroxisomeproliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes.
  17. (2005). Fan ST: Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res
  18. (2000). FD: Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol
  19. (2005). FU: Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells. Mod Pathol
  20. (2007). Garcia-Atares N: TrkC: a new predictive marker in breast cancer? Cancer Invest
  21. (2004). Garderen E, Peeper DS: Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature
  22. (1998). Hartvig HB: Organochlorine exposure and risk of breast cancer. Lancet
  23. (2008). Hondermarck H: Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res
  24. (1998). Hondermarck H: Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells.
  25. (2004). Hondermarck H: Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets
  26. (2001). Hondermarck H: Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways.
  27. (2007). Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma. Cancer Genet Cytogenet
  28. (2008). JH: BDNF and memory formation and storage. Neuroscientist
  29. Le Bourhis X: Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer 9:157.
  30. (2006). Lewis DK: Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol
  31. (2001). Nakagawara A: Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett
  32. (2001). Neurotrophins and neurotrophin receptors in human lung cancer.
  33. (2000). Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev
  34. (2004). Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells.
  35. (1996). Physiology of the neurotrophins. Annu Rev Neurosci
  36. (2001). Pour PM: Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer.
  37. (2003). RE: Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res
  38. (2003). Reichardt LF: Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem
  39. (2006). TC: Brain-derived neurotrophic factor promotes growth and migration of multiple myeloma cells. Cancer Genet Cytogenet
  40. (2006). The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell Mol Life Sci
  41. (2002). The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic Patani et al.
  42. (2002). Thiele CJ: Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapyinduced apoptosis via phosphatidylinositol 3’-kinase pathway. Cancer Res
  43. (2006). Thiele CJ: Brainderived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res
  44. (2007). Thiele CJ: Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Mol Cancer Ther
  45. (2009). Timmusk T: Meta-coexpression conservation analysis of microarray data: a “subset” approach provides insight into brain-derived neurotrophic factor regulation.
  46. (2009). WG: Developmental and lactational exposure to dieldrin alters mammary tumorigenesis in Her2/neu transgenic mice. PLoS One
  47. (2008). X: Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci
  48. X: TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells.
  49. (2008). Zaenker KS: The cancer’s nervous tooth: Considering the neuronal crosstalk within tumors. Semin Cancer Biol